Strategies for targeting cytokines in inflammatory bowel disease

MF Neurath - Nature Reviews Immunology, 2024 - nature.com
Cytokines produced by immune cells contribute to the development and perpetuation of
inflammatory bowel disease (IBD), namely Crohn's disease and ulcerative colitis, by …

IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

B Verstockt, A Salas, BE Sands, C Abraham… - Nature Reviews …, 2023 - nature.com
Abstract Interleukin-12 (IL-12) and interleukin-23 (IL-23), which belong to the IL-12 family of
cytokines, have a key role in intestinal homeostasis and inflammation and are implicated in …

[HTML][HTML] The influence of cytokines on the complex pathology of ulcerative colitis

H Nakase, N Sato, N Mizuno, Y Ikawa - Autoimmunity Reviews, 2022 - Elsevier
Ulcerative colitis (UC) specifically affects the colon and rectum through multifactorial
mechanisms associated with genetic alterations, environmental factors, microbiota, and …

[HTML][HTML] Role and mechanism of gut microbiota in human disease

Y Chen, J Zhou, L Wang - Frontiers in cellular and infection …, 2021 - frontiersin.org
The human gut microbiome is a huge microbial community that plays an irreplaceable role
in human life. With the further development of research, the influence of intestinal flora on …

[HTML][HTML] Challenges, progress, and prospects of develo** therapies to treat autoimmune diseases

L Fugger, LT Jensen, J Rossjohn - Cell, 2020 - cell.com
Autoimmune diseases are a result of the immune system being misdirected toward its host
and have major and increasing unmet clinical needs. In general, present therapies are …

FADD and caspase-8 regulate gut homeostasis and inflammation by controlling MLKL-and GSDMD-mediated death of intestinal epithelial cells

R Schwarzer, H Jiao, L Wachsmuth, A Tresch… - Immunity, 2020 - cell.com
Pathways controlling intestinal epithelial cell (IEC) death regulate gut immune homeostasis
and contribute to the pathogenesis of inflammatory bowel diseases. Here, we show that …

Epithelial-derived interleukin-23 promotes oral mucosal immunopathology

TS Kim, T Ikeuchi, VI Theofilou, DW Williams… - Immunity, 2024 - cell.com
At mucosal surfaces, epithelial cells provide a structural barrier and an immune defense
system. However, dysregulated epithelial responses can contribute to disease states. Here …

[HTML][HTML] Oral ritlecitinib and brepocitinib for moderate-to-severe ulcerative colitis: results from a randomized, phase 2b study

WJ Sandborn, S Danese, J Leszczyszyn… - Clinical …, 2023 - Elsevier
Background & Aims The efficacy and safety of ritlecitinib (oral JAK3/TEC family kinase
inhibitor) and brepocitinib (oral TYK2/JAK1 inhibitor) as induction therapy were assessed in …

[HTML][HTML] A narrative review of cytokine networks: pathophysiological and therapeutic implications for inflammatory bowel disease pathogenesis

M Vebr, R Pomahačová, J Sýkora, J Schwarz - Biomedicines, 2023 - mdpi.com
Inflammatory bowel disease (IBD) is a lifelong inflammatory immune mediated disorder,
encompassing Crohn's disease (CD) and ulcerative colitis (UC); however, the cause and …

IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy

JG Krueger, K Eyerich, VK Kuchroo… - Frontiers in …, 2024 - frontiersin.org
Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory
cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including psoriasis …